An Incremental Effectiveness Analysis Of Lorlatinib For The Treatment Of Alk-Positive Advanced Non-Small Cell Lung Cancer That Has Progressed After Another Alk Tyrosine Kinase Inhibitor In Portugal
AuthID
P-00T-FTH
P-00T-FTH